Correspondence
Brown’s syndrome during pregnancy: a case report and review of literature
Brown’s syndrome is an uncommon strabismus characterized by restriction of elevation in adduction and can be congenital or acquired.1–3 Clinical features include mild impaired elevation on upgaze, minimal/no elevation deficit on abduction, and minimal/no superior oblique overaction.1–3Detection of plastic BBs on CT scanning of the orbit
A 25-year-old male was referred to our ophthalmology service after accidentally shooting himself in the right periocular area with a BB pellet gun. According to the patient, the gun had fired a single spherical, red plastic BB pellet approximately 5 mm in diameter. He experienced immediate decreased vision and floaters and was initially seen in a peripheral emergency department. He did not recover the BB. A computed tomography (CT) scan of the orbits performed at the peripheral hospital was reported as negative for a foreign body.Re: Johnson et al. Drug-prescribing patterns among optometrists and nonophthalmologist physicians at a tertiary care centre in Kingston, Ontario
We thank Drs. Goodhew and Thienes for sharing their comments regarding our recent article on the prescribing of medications for ocular conditions by nonophthalmologist physicians and optometrists. Our prospective study encompassed 1 year of referrals to an emergency eye clinic at a tertiary care hospital in a unique setting where 1 emergency eye service captures virtually all urgent referrals in a large region of Ontario. Within this large series a number of important findings were observed. Based on our data set, which provides only a small window on optometry prescribing, it is important that we avoid making overly specific recommendations and refrain from political commentary.Emergency department visits after intravitreal bevacizumab and ranibizumab injections in diabetic patients
Bevacizumab (Avastin; Genentech, San Francisco, CA, USA) and ranibizumab (Lucentis; Genentech) are both inhibitors of vascular endothelial growth factor (VEGF). They are used intravitreally in the treatment of a variety of ocular diseases including age-related macular degeneration (AMD),1,2 diabetic macular edema (DME),3–7 proliferative retinopathy,8 retinal vein occlusion,9 and others.10,11
